Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic Multicentric Castleman Disease Successfully Treated with Tocilizumab: A Case Report

被引：0

作者：

Wada, Takuma Tsuzuki ^{[1
]}

Yokota, Kazuhiro ^{[1
]}

Okada, Mariko ^{[2
]}

Ichimura, Takaya ^{[3
]}

Ueno, Takehito ^{[1
]}

Okumura, Nobuhito ^{[1
]}

Osawa, Iichiro ^{[4
]}

Inoue, Kaiji ^{[4
]}

Akiyama, Yuji ^{[1
]}

Nakazato, Yoshihiko ^{[2
]}

Sasaki, Atsushi

Yamamoto, Toshimasa ^{[2
]}

Mimura, Toshihide ^{[1
]}

机构：

[1] Saitama Med Univ, Fac Med, Dept Rheumatol & Appl Immunol, Irama, Japan

[2] Saitama Med Univ, Fac Med, Dept Neurol, Saitama, Japan

[3] Saitama Med Univ, Fac Med, Dept Pathol, Saitama, Japan

[4] Saitama Med Univ Hosp, Dept Radiol, Saitama, Japan

来源：

INTERNAL MEDICINE | 2024年

关键词：

neuromyelitis optica spectrum disorder; Castleman disease; interleukin-6; tocilizumab; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; DIAGNOSTIC-CRITERIA; EFFICACY; PLASMABLASTS; SATRALIZUMAB; AQUAPORIN-4; SAFETY;

D O I：

10.2169/internalmedicine.4503-24

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report a 52-year-old woman with anti-aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) and idiopathic multicentric Castleman disease (iMCD) who was successfully treated with tocilizumab, a humanized anti-human interleukin (IL)-6 receptor monoclonal antibody. This is the first report of a case of coexisting NMOSD and iMCD. IL-6 is involved in the pathogenesis of both NMOSD and iMCD, and tocilizumab is effective against both diseases. By treating the patient with tocilizumab, the lung lesions due to iMCD improved, and the neurological symptoms of NMOSD did not recur.

引用

页数：7

共 50 条

[21] A curious case of neuromyelitis optica spectrum disorder co -existing with idiopathic intracranial hypertension
Viswanathan, S.
Wong, L. C.
JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 41 : 104 - 106
[22] Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease
Takeshi Tosaki
Masahiro Okabe
Tomo Suzuki
Akihiro Shimizu
Kentaro Koike
Nobuo Tsuboi
Tetsuya Kawamura
Ryuji Ohashi
Shingo Yano
Takashi Yokoo
CEN Case Reports, 2021, 10 : 265 - 272
[23] A Case Report of Seropositive Neuromyelitis Optica Spectrum Disorder
Atit, Priyanka
Schneider, Jean-Raphael
ANNALS OF NEUROLOGY, 2021, 90 : S16 - S16
[24] FingolimodExacerbation of neuromyelitis optica spectrum disorder: case report
Reactions Weekly, 2013, 1468 (1) : 21 - 21
[25] Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report
Lang, Evan
Sande, Brenda
Brodkin, Samantha
van Rhee, Frits
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
[26] Neuromyelitis optica spectrum disorder coinciding with hematological immune disease: A case report
Patejdl, R.
Wittstock, M.
Zettl, U. K.
Jost, K.
Grossmann, A.
Prudlo, J.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 101 - 103
[27] Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab
Shidahara, K.
Hayashi, K.
Sada, K. E.
Hiramatsu, S.
Morishita, M.
Watanabe, H.
Matsumoto, Y.
Kawabata, T.
Wada, J.
LUPUS, 2018, 27 (08) : 1374 - 1377
[28] Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report
Yokoyama, N.
Niino, M.
Takahashi, T.
Matsushima, M.
Maruo, Y.
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (12) : E143 - E143
[29] Rehabilitation and pharmacotherapy of neuromyelitis optica spectrum disorder: A case report
Xiao-Ju Wang
Peng Xia
Ting Yang
Kai Cheng
An-Liang Chen
Xue-Ping Li
World Journal of Clinical Cases, 2021, 9 (16) : 3951 - 3959
[30] NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
George, J.
Kitley, J.
Leite, M. I.
Elston, J. S.
Matthews, B. N.
Cortes, N.
Donati, M.
Jones, N.
Palace, J. A.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83

← 1 2 3 4 5 →